Transasia Bio-Medicals' unveils hematology range in TS

Hyderabad: Transasia Bio-Medicals Ltd., an In-vitro Diagnostic (IVD) company on Sunday as part of its 40th anniversary celebration announced that its international hematology range, is now available in Telangana.

Backed by European R&D, the 3-Part Differential (3PD) to 5-Part Differential (5PD) fully automated haematology analysers, reagents and controls include a number of features to help institutions, clinicians and lab technologists offer accurate diagnosis.

Hematology analysers are extensively used in patient and research settings to count and characterize blood cells for disease detection and monitoring. Sophisticated analysers measure cell morphology and can detect small cell populations to diagnose rare blood conditions.

The new hematology range are relevant for Telangana, where recent studies have shown growing number of children born have unique and high incidence of hemoglobinopathies like thalassemia and sickle cell anaemia.

Addressing the media, Suresh Vazirani, CMD, Transasia Bio-Medicals Ltd., said, "Telangana is very close to our heart as Hyderabad is where we established our first zonal office in India and also sold our first cell counter in 1983.

3-4 years ago, the Telangana State Medical Services Infrastructure Development Corporation (TSMSIDC), which was established for equitable access to drugs and diagnostic services, especially in the interiors of the state, trusted Transasia by purchasing 5-part differential haematology analysers for 13-15 medical college hospitals in remote areas.

Today every district hospital in Telangana has a Transasia equipment. That is how closely we have been associated with serving the people of the state and we hope with the new range that this close association only grows further."